Cargando…
Cardiovascular magnetic resonance imaging in early anthracycline cardiotoxicity
Autores principales: | Smith, Gillian, Kotwinski, Paul, Carpenter, John Paul, Hugh, Montgomery, Pennell, Dudley |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7860834/ http://dx.doi.org/10.1186/1532-429X-11-S1-P18 |
Ejemplares similares
-
CMR shows that anthracycline cardiotoxicity is common in women treated for early breast cancer and associated with undiagnosed hypertension; but cannot be reliably detected using late-gadolinium enhancement imaging
por: Kotwinski, Paul, et al.
Publicado: (2013) -
Body Surface Area and Baseline Blood Pressure Predict Subclinical Anthracycline Cardiotoxicity in Women Treated for Early Breast Cancer
por: Kotwinski, Paul, et al.
Publicado: (2016) -
The breast cancer, early disease: toxicity from therapy with epirubicin regimens - cardiac assessment and risk evaluation (BETTER-CARE) study: CMR with early gadolinium relative enhancement, but not high-sensitivity troponin T, predicts the risk of chronic anthracycline cardiotoxicity
por: Kotwinski, Paul, et al.
Publicado: (2013) -
Cardiac magnetic resonance characteristics of acute anthracycline-induced cardiotoxicity
por: Toro-Salazar, Olga H, et al.
Publicado: (2016) -
Myocardial iron assessment by T2* cardiovascular magnetic resonance at 3 Tesla
por: Alam, Mohammed H, et al.
Publicado: (2014)